NCT00886522
- Conditions
- Graft vs Host Disease, Hematologic Diseases, Hematologic Neoplasms, +5 more
- Locations
-
- Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi University Hospital Bologna, Italy
Clinical trial condition
Hematological Malignancies
Explore clinical trials studying Hematological Malignancies. Study availability and eligibility vary by location and protocol.
98 public trials
21 recruiting studies
Hematological Malignancies trial results
Completed
Association Between Side Effects Occurrence and Concentrations of Ibrutinib and Idelalisib
NCT02824159
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- Cancer University Institute of Toulouse Oncopole Toulouse, France
NCT01830010
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- Novartis Investigative Site Paris, France
- Novartis Investigative Site Regensburg, Bavaria, Germany
- Novartis Investigative Site Cologne, Germany
- Novartis Investigative Site Freiburg im Breisgau, Germany
Completed
Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM
NCT01816230
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +18 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Loyola University, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
- University of Minnesota Minneapolis, Minnesota, United States
- Steven and Alexandra Cohen Children's Medical Center New York, United States
Completed
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
NCT00179764
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +33 more
- Locations
-
- Lurie Children's Hospital Chicago, Illinois, United States
NCT00047489
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
NCT00824993
- Conditions
- Bone Diseases, Bone Diseases, Metabolic, Hematologic Diseases, +9 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT
NCT01246206
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +34 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
NCT02834156
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- CHU de Nice Nice, France
NCT01627275
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States